Preoperative iron deficiency anemia (IDA) significantly impacts colorectal cancer (CRC) patients, with up to 80% experiencing iron deficiency. This condition predisposes them to increased risk of allogeneic blood transfusion, postoperative complications, prolonged hospital stays, and higher mortality. An effective strategy for managing IDA involves using the reticulocyte hemoglobin equivalent as a diagnostic tool and administering intravenous iron formulations. Reducing reliance on blood transfusions is crucial due to their associated morbidity and increased cancer recurrence risks.
Review by Rudzki J, Polewka M (…) Czempik PF et 3 al. in Pol Przegl Chir